However, previous studies only focused on quantifying LCN2 concentrations in patients with confirmed BM and viral encephalitis, and did not compare the performance of LCN2 against commonly used CSF markers such as leukocytes, glucose, protein and lactate. The gene discussed is LCN2; the disease is viral encephalitis.